The manufacturer received information alleging a cpap device's sound abatement foam became degraded and caused a cough, nasal discharge, decreased oxygenation from 03/11/2021 through 06/05/2022.The patient did report to receive medical intervention and saw a pulmonologis, prescribed several medications and had a chest x-ray.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
|
The manufacturer previously reported an allegation of an issue related to sound abatement foam. additional information was received and section b5 should be reported as: the manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging an issue related to a continuous positive airway pressure (cpap) device's sound abatement foam became degraded and caused a patient to develop cough, nasal discharge, decreased oxygenation from 03/11/2021 through 06/05/2022.There was medical intervention required by the patient.The reported events of cough, nasal discharge, decreased oxygenation and its reported severity was reviewed by the manufacture's clinical expert.These events are assessed as not related to the device in this case.Based on the available information, the manufacture concludes no further action is necessary the device has not yet returned to the manufacturer for evaluation.The patient has swapped out the device at the distributor and at this time, no further investigation can be performed.If any additional information is received, a follow up report will be filed. sections b1, b2, has changed related to the complaint changing from the reported adverse event to a product problem.Section h1 has changed to reflect a malfunction.Section g2 was corrected, h6 health effect- impact code, type of investigation findings and investigation conclusions has been updated.
|